Thursday, May 7, 2015 6:09 PM
|
CCSVI in Multiple Sclerosis
It's astonishing researchers can get their work published when it contains a misleading headline and speculative, unsubstantiated conclusions. This study only had two people fulfilling the CCSVI criteria in a sample size of 32, which alone puts their methodology into question. Poor science – but it will fuel those who think the venous hypothesis is dead. (edit from Joan--Thanks to Sandra for posting. Disclosures are important. This is their 4th paper on the "lie" of CCSVI. Ralf Gold has received personal compensation and grant support from BiogenIdec, BayerSchering, Novartis, MerckSerono, Sanofi-Genzyme, Roche, TEVA) http://www.ncbi.nlm.nih.gov/pubmed/25891137/Brain Hyperechogenicities are not Associated with Venous Insufficiency in Multiple Sclerosis: A...www.ncbi.nlm.nih.gov J Neuroimaging. 2015 Apr 19. doi: 10.1111/jon.12248. [Epub ahead of print]
|